Amarin Receives Approval for VAZKEPA to Reduce Cardiovascular Risk
A round of applause for our research site physicians Dr Sam Henein and Dr Michael O’Mahony for their participation in the Amarin REDUCE-IT hypertriglyceridemia study!
We have written a number of articles that we hope will be of interest to you. This includes health guides for various medical conditions; news about drug development and regulatory issues related to Health Canada and the FDA; and other health-related topics. Clicking on the title of a Health Guide will take you to information on that medical condition. Or click on one of the listed topics, such as Industry News or Diabetes. You can also access recent articles by scrolling down the page or clicking an article under ‘Recent Articles’.
A round of applause for our research site physicians Dr Sam Henein and Dr Michael O’Mahony for their participation in the Amarin REDUCE-IT hypertriglyceridemia study!
A groundbreaking study from the University of Auckland has found that a single fecal microbiota transplant (FMT) can provide obese teenagers with years of health benefits. FMT involves transferring gut bacteria from healthy donors to patients—in this case, through capsules swallowed over two days. While the idea may sound unappealing, the results are remarkable. The